Aptevo Biotherapeutics competitive analysis

Loading summary...

Explore patent oppositions filed by Aptevo Biotherapeutics against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 23, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Recombinant Co-Expression Of Vitamin K Epoxide Reductase Subunit 1 To Improve Vitamin K Dependant Protein ExpressionBAXALTAJun 18, 2018

Latest publications and patents of Aptevo Biotherapeutics New

Explore the latest publications and patents granted to Aptevo Biotherapeutics, showcasing their recent innovations and technological advancements.

Latest PTAB cases involving Aptevo Biotherapeutics

Discover the latest PTAB cases involving Aptevo Biotherapeutics, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Aptevo Biotherapeutics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
APTEVO BIOTHERAPEUTICS1 - - -
BAXALTA520 - -
BAXALTA INCORPORATED - 20 - -
BAXTER927515